Making Stem Cells

Compatible

with Everyone

Embryoid bodies, fluorescent light micrograph

Editing Stem Cells to Cure Disease

3D rendering of recombinant Adeno-Associated Virus

rAAV

Universal Cells creates Universal Donor Stem Cells by editing the genes required for immune recognition. By using our recombinant Adeno-Associated Virus (rAAV) technology, we design and manufacture stem cell-based products that can be used as off-the-shelf cell therapies.

Our Technology

One Universal Stem Cell Bank

rAAV

Universal Donor Cells are pluripotent and can differentiate into various cell types that can be used to treat a vast number of diseases. Learn more about the Universal Cells’ pipeline and partnerships.

Pipeline

Latest News

Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology

October 20th, 2017|0 Comments

Tokyo, October 19, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Universal Cells, Inc. (CEO: Claudia Mitchell, “Universal Cells”) today announced that Astellas Institute for Regenerative Medicine (“AIRM”) and [...]

Cell and Gene Therapy Catapult Licenses iPSC Line to Universal Cells to assist in the Development of Universal Donor Cell Line

October 5th, 2017|0 Comments

Universal Cells to utilise CGT Catapult’s induced Pluripotent Stem Cells to create universally accepted cells for research and commercial use London, UK, 5 October 2017 – The Cell and Gene Therapy Catapult (CGT Catapult) today [...]

BlueRock Therapeutics and Universal Cells Enter Collaboration and License Agreement to Generate Gene-Edited iPS Cell Lines

October 3rd, 2017|0 Comments

CAMBRIDGE, MA and SEATTLE, WA, October 3, 2017-BlueRock Therapeutics and Universal Cells Inc. today announced that they have entered into a collaboration and license agreement to create induced pluripotent stem (iPS) cell lines useful for [...]